Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Allegiance Resources Acquires Three British Columbia Tungsten Projects

Allegiance Resources Acquires Three British Columbia Tungsten Projects

BitgetBitget2026/11/05 12:15
  • Allegiance Resources acquired 100% interests in three British Columbia tungsten projects: Thanksgiving, Five T's and Rio Grande.
  • Consideration included 1,200,000 common shares at a deemed price of $0.175 each, totaling $210,000.
  • Cash payments comprise $30,000 paid upon signing on September 27, 2026, with $30,000 due March 27, 2027.
  • Claim holders received a 2% net smelter returns royalty; 1% can be repurchased for $1 million before commercial production.
  • Other vendors received a 1% net smelter returns royalty; 0.5% can be repurchased for $500,000 before commercial production.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allegiance Resources Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611050700NEWSFILECNPR____20261105_322664_1) on November 05, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss